Discusses Oncology Pipeline Advances and Phase III Clinical Updates at Science and Technology Day December 15, ...

Datroway is an antibody drug conjugate discovered by Tokyo-based pharmaceutical maker Daiichi Sankyo. It is being jointly developed and commercialised with Cambridge, England-based AstraZeneca PLC.

Daiichi Sankyo and AstraZeneca have pressed swiftly to file for approval of their TROP2-targeting drug Datroway for ...

The European Medicines Agency (EMA) has validated the Type II Variation marketing authorization application for DATROWAY ® (datopotamab deruxtecan) as monotherapy for the first-line treatment of adult ...

EMA validates Type II Variation marketing authorization application of Datroway as first-line treatment for patients with metastatic TNBC who are not candidates for immunotherapy ...

AstraZeneca and Daiichi Sankyo’s Enhertu, in combination with pertuzumab, has been approved by the US FDA to treat adult ...

US FDA approves AstraZeneca and Daiichi Sankyo’s Enhertu plus pertuzumab for 1st-line treatment of patients with HER2-positive metastatic breast cancer: Cambridge, UK Wednesday, ...

Drugmaker AstraZeneca chalked up two regulatory wins on Tuesday, with approvals in both the US and Europe for key treatments ...

E-cigarettes, nicotine pouches, and heated tobacco hurt blood vessels, increase heart disease risk. All nicotine products ...

Nicotine is toxic to the heart and blood vessels, regardless of whether it is consumed via a vape, a pouch, a shisha or a cigarette, according to an expert consensus report published in the European ...

UNIONDALE, NY / ACCESS Newswire / December 15, 2025 / Marquis Who's Who honors Michael J. Agerbeck for his expertise in ...

Richards Packaging Income Fund (the "Fund" or "Richards Packaging") announced today receipt of the final order of the Ontario Superior Court of Justice with respect to the approval of the statutory ...